Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
These findings represent substantial improvements over traditional anti-obesity medications and approach the efficacy levels historically associated with bariatric surgery
Understanding how it compares to alternatives helps you make informed decisions
Immunoturbidimetric assays were used to determine serum apolipoprotein A1 (apoA1), apolipoprotein B (apoB), lipoprotein (a) (Lp (a)) [Shanghai Kehua Bio-engineering Co., LTD, Shanghai, China] and hypersensitivity C reactive protein (Hs-CRP) [Orion Diagnostica Oy, Espoo, Finland] levels
To explore differences in (i) past-year use of GLP-1 or GLP-1/GIP medication to support weight loss and (ii) interest in using a weight-loss medication in the next year between population subgroups, we estimated these proportions stratified by gender, age, ethnicity, occupational social grade, financial situation, health-related economic inactivity, smoking status, alcohol consumption, past-month distress, and history of eating disorders
